Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Relevance of Abnormal Airway Morphology in Asthma: A Path to Optimized Management and Drug Development (AirPATH Study)

NCT06970080 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT06970080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06970080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Relevance of Abnormal Airway Morphology in Asthma: A Path to Optimized Management and Drug Development (AirPATH Study)
Lead sponsor
McMaster University
Phase
Phase 4
Overall status
Recruiting
Start date
June 2, 2025
Completion date
June 30, 2028
Enrollment
242 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma